Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR

Clinical trial NCT01611298 · COMPLETED

Trial details

NCT number: NCT01611298
Sponsor: Robert Krance
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Acute Myelogenous Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndrome Hodgkin Lymphoma Non-Hodgkin Lymphoma

Start date: 2008-03-01
Primary completion: 2012-11-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.